Patents by Inventor Roopal B. Thakkar

Roopal B. Thakkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating crohn's disease and ulcerative colitis
    Patent number: 11564922
    Abstract: The present disclosure is directed to methods for treating Crohn's disease, and in particular, to methods for inducing clinical remission and/or endoscopic improvement of Crohn's disease, using a JAK1 inhibitor. In certain embodiments, the patient is administered an induction dose of the JAK1 inhibitor to induce clinical remission and/or endoscopic improvement of the Crohn's disease, followed by administration of at least one maintenance dose of the JAK1 inhibitor thereafter. In other embodiments, the present disclosure is directed to methods for treating ulcerative colitis using a JAK1 inhibitor.
    Type: Grant
    Filed: April 28, 2022
    Date of Patent: January 31, 2023
    Assignee: AbbVie Inc.
    Inventors: Aileen L. Pangan, Roopal B. Thakkar, Steven Jungerwirth, Ana Paula Machado De Lacerda, Anne M. Robinson, Mohamed-Eslam F. Mohamed, Ahmed A. Othman, Ben Klünder, Wen Zhou
  • METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS
    Publication number: 20220273651
    Abstract: The present disclosure is directed to methods for treating Crohn's disease, and in particular, to methods for inducing clinical remission and/or endoscopic improvement of Crohn's disease, using a JAK1 inhibitor. In certain embodiments, the patient is administered an induction dose of the JAK1 inhibitor to induce clinical remission and/or endoscopic improvement of the Crohn's disease, followed by administration of at least one maintenance dose of the JAK1 inhibitor thereafter. In other embodiments, the present disclosure is directed to methods for treating ulcerative colitis using a JAK1 inhibitor.
    Type: Application
    Filed: April 28, 2022
    Publication date: September 1, 2022
    Applicant: AbbVie Inc.
    Inventors: Aileen L. Pangan, Roopal B. Thakkar, Steven Jungerwirth, Ana Paula Machado De Lacerda, Anne M. Robinson, Mohamed-Eslam F. Mohamed, Ahmed A. Othman, Ben Klünder
  • METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS
    Publication number: 20210361647
    Abstract: The present disclosure is directed to methods for treating Crohn's disease, and in particular, to methods for inducing clinical remission and/or endoscopic improvement of Crohn's disease, using a JAK1 inhibitor. In certain embodiments, the patient is administered an induction dose of the JAK1 inhibitor to induce clinical remission and/or endoscopic improvement of the Crohn's disease, followed by administration of at least one maintenance dose of the JAK1 inhibitor thereafter. In other embodiments, the present disclosure is directed to methods for treating ulcerative colitis using a JAK1 inhibitor.
    Type: Application
    Filed: December 9, 2020
    Publication date: November 25, 2021
    Inventors: Roopal B. Thakkar, Steven Jungerwirth, Ana Paula Machado de Lacerda, Ann M. Robinson, Jose Jeffrey V. Enejosa, Aileen L. Pangan, Mohamed-Eslam F. Mohamed, Ahmed A. Othman, Ben Klunder, Ayman D. Allian
  • METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS
    Publication number: 20190046527
    Abstract: The present disclosure is directed to methods for treating Crohn's disease, and in particular, to methods for inducing clinical remission and/or endoscopic improvement of Crohn's disease, using a JAK1 inhibitor. In certain embodiments, the patient is administered an induction dose of the JAK1 inhibitor to induce clinical remission and/or endoscopic improvement of the Crohn's disease, followed by administration of at least one maintenance dose of the JAK1 inhibitor thereafter. In other embodiments, the present disclosure is directed to methods for treating ulcerative colitis using a JAK1 inhibitor.
    Type: Application
    Filed: March 9, 2018
    Publication date: February 14, 2019
    Inventors: Roopal B. THAKKAR, Steven JUNGERWIRTH, Ana Paula Machado de LACERDA, Anne M. ROBINSON, Jose Jeffrey V. ENEJOSA, Aileen L. PANGAN, Mohamed-Eslam F. MOHAMED, Ahmed A. OTHMAN, Ben KLÜNDER
  • METHODS FOR DETERMINING HOW TO TREAT CONGESTIVE HEART FAILURE
    Publication number: 20080077025
    Abstract: The present invention relates to methods for determining how to treat congestive heart failure.
    Type: Application
    Filed: July 11, 2006
    Publication date: March 27, 2008
    Inventors: Leticia Delgado-Herrera, Robert J. Padley, Jeffrey E. Salon, Roopal B. Thakkar, Bidan Huang